Colgate-Palmolive’s (NYSE: CL) stock faced a downturn as the company’s future guidance failed to align with investor expectations, despite a strong fourth-quarter earnings beat. The personal care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback